Clincosm LogoSign in Get a demo

anticoagulant

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anticoagulant, Venous Thromboembolism, Prophylaxis Trial in Denmark (Dalteparin Prefilled Syringe, Tinzaparin profiled syringe)

Recruiting
  • Anticoagulant
  • +3 more
  • Dalteparin Prefilled Syringe
  • Tinzaparin profiled syringe
  • Copenhagen, Denmark
  • +8 more
Aug 29, 2023

Anticoagulant Trial (Heparin)

Not yet recruiting
  • Anticoagulant
  • Heparin
  • (no location specified)
Mar 15, 2023

Anticoagulant Trial (Heparin)

Not yet recruiting
  • Anticoagulant
  • Heparin
  • (no location specified)
Mar 15, 2023

Venous Thrombosis, Tumors, Anticoagulant Trial in Kyoto (12-month Edoxaban, 3-month Edoxaban)

Active, not recruiting
  • Venous Thrombosis
  • +2 more
  • 12-month Edoxaban
  • 3-month Edoxaban
  • Kyoto, Japan
    Department of Cardiovascular Medicine, Kyoto University Graduate
Aug 16, 2022

Venous Thromboembolism, Anticoagulant, Elderly Trial in Rozzano (Sulodexide, Sulodexide and , Placebo)

Recruiting
  • Venous Thromboembolism
  • +2 more
  • Rozzano, Italy
    Corrado Lodigiani
Jul 19, 2022

Infarction Volume on Hemorrhagic Transformation in Ischemic

Recruiting
  • Cerebrovascular Stroke
  • +3 more
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
May 5, 2022

Anticoagulant, Pharmacogenetics, Community Pharmacy Services Trial in Zaragoza (acenocoumarol, control)

Completed
  • Anticoagulant
  • +4 more
  • acenocoumarol
  • control
  • Zaragoza, Spain
    Centro de Salud Arrabal
May 3, 2021

Anticoagulant Trial in Seoul (Lixiana(D006), CKD-344)

Recruiting
  • Anticoagulant
  • Seoul, Korea, Republic of
    H+ Yangji Hospital
Apr 27, 2021

Anticoagulant Trial in Seoul (Lixiana(D006), CKD-344)

Recruiting
  • Anticoagulant
  • Seoul, Korea, Republic of
    Yook-Hwan Noh
Dec 16, 2020

Venous Thromboembolism in France:National Survey Among Vascular

Recruiting
  • Survey
  • +4 more
    • Amiens, France
      CHU Amiens
    Dec 4, 2020

    Anticoagulant Trial (WD-1602, Pradaxa®)

    Unknown status
    • Anticoagulant
    • (no location specified)
    Oct 29, 2020

    Protein S100b in Mild Head Trauma Under Anti-thrombotics

    Unknown status
    • Mild Head Injury
    • +2 more
    • Dosage of S100β protein
    • Rennes, France
      Centre Hospitalier Universitaire de Rennes
    May 6, 2020

    Examine Need to Adjust Dose of Apixaban When Used in Atrial

    Completed
    • Anticoagulant
    • +2 more
    • Anti Xa levels
    • Afula, Israel
      HaEmek Medical Center
    Mar 31, 2020

    Determinants of Oral Anticoagulants' Activity

    Terminated
    • Anticoagulant
    • PK-PD genetic polymorphisms
    • Lille, France
      University Hospital
    Oct 15, 2019

    Acute Ischemic Stroke, Atrial Fibrillation, Extracranial Atherosclerosis Trial in Seoul (Edoxaban Monotherapy)

    Recruiting
    • Acute Ischemic Stroke
    • +7 more
    • Edoxaban Monotherapy
    • Seoul, Korea, Republic of
      Asan Medical Center
    Oct 10, 2019

    Evaluation of Patient's Knowledge of Their NACO Treatment

    Completed
    • Anticoagulant
      • Paris, Ile-de-France, France
        Groupe Hospitalier Paris Saint Joseph
      Feb 26, 2018